Close Lucintel Chat
Didn't Find What You're Looking for?
Call us at +1972 636 5056 or write at helpdesk@Lucintel.com
Ask an Expert Provide Custom Requirements Download Sample Report Search Available Reports
  • helpdesk@Lucintel.com
  • |
  • Call Lucintel +1 972 636 5056
  • |
  • Login
  • |
  • Register
  • |
  • Search
  • |
'
...

The Impact of COVID-19 is included in Nanoparticle Contract Manufacturing Market Report. Buy it today to get an advantage.

Request the impact of COVID-19 on your product or industry


Nanoparticle Contract Manufacturing Trends and Forecast

The future of the global nanoparticle contract manufacturing market looks promising with opportunities in the therapeutic, diagnostic, and vaccinee markets. The global nanoparticle contract manufacturing market is expected to reach an estimated $3 billion by 2030 with a CAGR of 7.1% from 2024 to 2030. The major drivers for this market are growing demand for nanomedicine applications, increasing demand for metal nanoparticles in cancer therapy, and rising adoption of therapeutics in the drug delivery applications.
Nanoparticle Contract Manufacturing Trends and Forecast

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Nanoparticle Contract Manufacturing by Segment

Nanoparticle Contract Manufacturing by Segment

The study includes a forecast for the global nanoparticle contract manufacturing by manufacturing scale, type of nanoparticles, application, end use, and region.

Nanoparticle Contract Manufacturing Market by Manufacturing Scale [Shipment Analysis by Value from 2018 to 2030]:


• Commercial
• Clinical
• Pre-Clinical

Nanoparticle Contract Manufacturing Market by Type of Nanoparticles [Shipment Analysis by Value from 2018 to 2030]:


• Metal Nanoparticles
• Lipid Nanoparticles
• Others

Nanoparticle Contract Manufacturing Market by Application [Shipment Analysis by Value from 2018 to 2030]:


• Therapeutics
• Diagnostics
• Vaccines
• Others

Nanoparticle Contract Manufacturing Market by End Use [Shipment Analysis by Value from 2018 to 2030]:


• Pharmaceutical Companies
• Biotechnology Companies

Nanoparticle Contract Manufacturing Market by Region [Shipment Analysis by Value from 2018 to 2030]:


• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Nanoparticle Contract Manufacturing Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies nanoparticle contract manufacturing companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the nanoparticle contract manufacturing companies profiled in this report include-
• AstraZeneca
• Evonik Industries
• Ascendia Pharmaceuticals
• Axolabs
• AVANSA Technology & Services
• Ardena
• Cytodiagnostics
• American Elements
• Encapsula NanoSciences
• Fortis Life Sciences

Nanoparticle Contract Manufacturing Market Insights

Lucintel forecasts that commercial is expected to witness the highest growth over the forecast period due to its broad use in many different industries, meeting high demand in the energy, electronics, and healthcare sectors.
Within this market, therapeutic is expected to witness the highest growth.
North America will remain the largest region over the forecast period due to its cutting-edge healthcare system and presence of well-known biotechnology and pharmaceutical companies in the region.

Features of the Global Nanoparticle Contract Manufacturing Market

Market Size Estimates: Nanoparticle contract manufacturing market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Nanoparticle contract manufacturing market size by various segments, such as by manufacturing scale, type of nanoparticles, application, end use, and region in terms of value ($B).
Regional Analysis: Nanoparticle contract manufacturing market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different manufacturing scale, types of nanoparticles, applications, end uses, and regions for the nanoparticle contract manufacturing market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the nanoparticle contract manufacturing market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.

FAQ

Q1. What is the nanoparticle contract manufacturing market size?
Answer: The global nanoparticle contract manufacturing market is expected to reach an estimated $3 billion by 2030.
Q2. What is the growth forecast for nanoparticle contract manufacturing market?
Answer: The global nanoparticle contract manufacturing market is expected to grow with a CAGR of 7.1% from 2024 to 2030.
Q3. What are the major drivers influencing the growth of the nanoparticle contract manufacturing market?
Answer: The major drivers for this market are growing demand for nanomedicine applications, increasing demand for metal nanoparticles in cancer therapy, and rising adoption of therapeutics in the drug delivery applications.
Q4. What are the major segments for nanoparticle contract manufacturing market?
Answer: The future of the nanoparticle contract manufacturing market looks promising with opportunities in the therapeutic, diagnostic, and vaccinee markets.
Q5. Who are the key nanoparticle contract manufacturing market companies?
Answer: Some of the key nanoparticle contract manufacturing companies are as follows:
• AstraZeneca
• Evonik Industries
• Ascendia Pharmaceuticals
• Axolabs
• AVANSA Technology & Services
• Ardena
• Cytodiagnostics
• American Elements
• Encapsula NanoSciences
• Fortis Life Sciences
Q6. Which nanoparticle contract manufacturing market segment will be the largest in future?
Answer: Lucintel forecasts that commercial is expected to witness the highest growth over the forecast period due to its broad use in many different industries, meeting high demand in the energy, electronics, and healthcare sectors.
Q7. In nanoparticle contract manufacturing market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region over the forecast period due to its cutting-edge healthcare system and presence of well-known biotechnology and pharmaceutical companies in the region.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

Q.1. What are some of the most promising, high-growth opportunities for the nanoparticle contract manufacturing market by manufacturing scale (commercial, clinical, and pre-clinical), type of nanoparticles (metal nanoparticles, lipid nanoparticles, and others), application (therapeutics, diagnostics, vaccines, and others), end use (pharmaceutical companies and biotechnology companies), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

For any questions related to Nanoparticle Contract Manufacturing Market, Nanoparticle Contract Manufacturing Market Size, Nanoparticle Contract Manufacturing Market Growth, Nanoparticle Contract Manufacturing Market Analysis, Nanoparticle Contract Manufacturing Market Report, Nanoparticle Contract Manufacturing Market Share, Nanoparticle Contract Manufacturing Market Trends, Nanoparticle Contract Manufacturing Market Forecast, Nanoparticle Contract Manufacturing Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.
Table of Contents

1. Executive Summary
2. Global Nanoparticle Contract Manufacturing Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges 
3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Nanoparticle Contract Manufacturing Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Nanoparticle Contract Manufacturing Market by Manufacturing Scale
3.3.1: Commercial
3.3.2: Clinical
3.3.3: Pre-Clinical
3.4: Global Nanoparticle Contract Manufacturing Market by Type of Nanoparticles
3.4.1: Metal Nanoparticles
3.4.2: Lipid Nanoparticles
3.4.3: Others
3.5: Global Nanoparticle Contract Manufacturing Market by Application
3.5.1: Therapeutics
3.5.2: Diagnostics
3.5.3: Vaccines
3.5.4: Others
3.6: Global Nanoparticle Contract Manufacturing Market by End Use
3.6.1: Pharmaceutical Companies
3.6.2: Biotechnology Companies
4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Nanoparticle Contract Manufacturing Market by Region
4.2: North American Nanoparticle Contract Manufacturing Market
4.2.1: North American Nanoparticle Contract Manufacturing Market by Manufacturing Scale: Commercial, Clinical, and Pre-Clinical
4.2.2: North American Nanoparticle Contract Manufacturing Market by Application: Therapeutics, Diagnostics, Vaccines, and Others
4.3: European Nanoparticle Contract Manufacturing Market
4.3.1: European Nanoparticle Contract Manufacturing Market by Manufacturing Scale: Commercial, Clinical, and Pre-Clinical
4.3.2: European Nanoparticle Contract Manufacturing Market by Application: Therapeutics, Diagnostics, Vaccines, and Others
4.4: APAC Nanoparticle Contract Manufacturing Market
4.4.1: APAC Nanoparticle Contract Manufacturing Market by Manufacturing Scale: Commercial, Clinical, and Pre-Clinical
4.4.2: APAC Nanoparticle Contract Manufacturing Market by Application: Therapeutics, Diagnostics, Vaccines, and Others
4.5: ROW Nanoparticle Contract Manufacturing Market
4.5.1: ROW Nanoparticle Contract Manufacturing Market by Manufacturing Scale: Commercial, Clinical, and Pre-Clinical
4.5.2: ROW Nanoparticle Contract Manufacturing Market by Application: Therapeutics, Diagnostics, Vaccines, and Others
5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Nanoparticle Contract Manufacturing Market by Manufacturing Scale
6.1.2: Growth Opportunities for the Global Nanoparticle Contract Manufacturing Market by Type of Nanoparticles
6.1.3: Growth Opportunities for the Global Nanoparticle Contract Manufacturing Market by Application
6.1.4: Growth Opportunities for the Global Nanoparticle Contract Manufacturing Market by End Use
6.1.5: Growth Opportunities for the Global Nanoparticle Contract Manufacturing Market by Region
6.2: Emerging Trends in the Global Nanoparticle Contract Manufacturing Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Nanoparticle Contract Manufacturing Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Nanoparticle Contract Manufacturing Market
6.3.4: Certification and Licensing
7. Company Profiles of Leading Players
7.1: AstraZeneca
7.2: Evonik Industries
7.3: Ascendia Pharmaceuticals
7.4: Axolabs
7.5: AVANSA Technology & Services
7.6: Ardena
7.7: Cytodiagnostics
7.8: American Elements
7.9: Encapsula NanoSciences
7.10: Fortis Life Sciences
.

Buy full report or by chapter as follows

Price by License Type:
[-] Hide Chapter Details
[Chapter Number] [Chapter Name] [Chapter Number Of Pages] [Chapter Price]
Title/Chapter Name Pages Price
Full Report: Nanoparticle Contract Manufacturing Market Report: Trends, Forecast and Competitive Analysis to 2030 Full Report $ 4,850
A 150 Page Report
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
  • In-depth interviews of the major players in this market
  • Detailed secondary research from competitors’ financial statements and published data 
  • Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
  • A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
 
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.